How the Gut, GLP-1 and Metabolic Health Connect Your gut is not separate from your metabolism
The delayed gastric emptying effect is dose-dependent, and anesthesiologists need to know you are taking it
GLP-1 agonists offer dual benefits of improved glycaemic control with minimal hypoglycaemia risk when used alone, and facilitation of weight loss
8:15 - HIV AND ALCOHOL SYNERGIZE TO SPREAD INFLAMMATION AND CELL DEATH IN PARENCHYMAL LIVER CELLS Globally, over 33million persons are living with HIV/AIDS, and 2.6million new infection yearly, despite Antiretroviral drugs, 1.8million deaths occur annually related to HIV infection, and liver-related disease accounts for 13-18% of all-cause mortality
Of note is that the observed median time to onset of the psychiatric AEs in our analysis of the FAERS data aligned with common gastrointestinal AEs such as nausea and vomiting, which were the most frequently reported within the first 30 days of GLP-1 RA treatment ( In this extensive pharmacovigilance study, we observed a significant association between GLP-1 RAs and eight distinct categories of psychiatric AEs, namely, nervousness, stress, eating disorder, fear of injection, sleep disorder due to general medical conditioninsomnia type, binge eating, fear of eating, and self-induced vomiting